DSV.DK

1,537.5

-0.26%↓

MAERSK.A.DK

16,500

-1.55%↓

VWS.DK

159.1

+1.95%↑

ROCK.B.DK

174.1

+4.67%↑

DNORD.DK

275

-0.51%↓

DSV.DK

1,537.5

-0.26%↓

MAERSK.A.DK

16,500

-1.55%↓

VWS.DK

159.1

+1.95%↑

ROCK.B.DK

174.1

+4.67%↑

DNORD.DK

275

-0.51%↓

DSV.DK

1,537.5

-0.26%↓

MAERSK.A.DK

16,500

-1.55%↓

VWS.DK

159.1

+1.95%↑

ROCK.B.DK

174.1

+4.67%↑

DNORD.DK

275

-0.51%↓

DSV.DK

1,537.5

-0.26%↓

MAERSK.A.DK

16,500

-1.55%↓

VWS.DK

159.1

+1.95%↑

ROCK.B.DK

174.1

+4.67%↑

DNORD.DK

275

-0.51%↓

DSV.DK

1,537.5

-0.26%↓

MAERSK.A.DK

16,500

-1.55%↓

VWS.DK

159.1

+1.95%↑

ROCK.B.DK

174.1

+4.67%↑

DNORD.DK

275

-0.51%↓

Search

FLSmidth & Co A-S

Cerrado

481.8 5.52

Resumen

Variación precio

24h

Actual

Mínimo

443.2

Máximo

487

Métricas clave

By Trading Economics

Ingresos

-962M

-151M

Ventas

620M

4.1B

P/B

Media del Sector

22.75

61.065

BPA

8.39

Rentabilidad por dividendo

0.71

Margen de beneficios

-3.707

Empleados

5,296

EBITDA

-76M

704M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+7.46% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.71%

2.23%

Próximas Ganancias

13 may 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

1.4B

29B

Apertura anterior

476.28

Cierre anterior

481.8

FLSmidth & Co A-S Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

23 mar 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mar 2026, 22:55 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mar 2026, 21:51 UTC

Adquisiciones, fusiones, absorciones

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mar 2026, 23:59 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

23 mar 2026, 23:59 UTC

Charlas de Mercado

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mar 2026, 23:50 UTC

Charlas de Mercado

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mar 2026, 23:37 UTC

Charlas de Mercado

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mar 2026, 22:42 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Global Equities Roundup: Market Talk

23 mar 2026, 22:42 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mar 2026, 22:40 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mar 2026, 22:23 UTC

Charlas de Mercado

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mar 2026, 22:22 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mar 2026, 22:21 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mar 2026, 22:21 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mar 2026, 22:20 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mar 2026, 22:20 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mar 2026, 22:19 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mar 2026, 22:19 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mar 2026, 22:18 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mar 2026, 22:15 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mar 2026, 22:08 UTC

Charlas de Mercado

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mar 2026, 21:42 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

23 mar 2026, 21:42 UTC

Charlas de Mercado

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mar 2026, 21:32 UTC

Ganancias

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mar 2026, 21:32 UTC

Ganancias

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mar 2026, 21:32 UTC

Ganancias

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mar 2026, 21:10 UTC

Noticias de Eventos Importantes

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mar 2026, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

23 mar 2026, 20:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

23 mar 2026, 20:50 UTC

Charlas de Mercado
Ganancias
Noticias de Eventos Importantes

Basic Materials Roundup: Market Talk

Comparación entre iguales

Cambio de precio

FLSmidth & Co A-S previsión

Precio Objetivo

By TipRanks

7.46% repunte

Estimación a 12 Meses

Media 343.86 DKK  7.46%

Máximo 400 DKK

Mínimo 280 DKK

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para FLSmidth & Co A-S Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

7 ratings

3

Comprar

3

Mantener

1

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de FLSmidth & Co A-S

FLSmidth & Co. A/S provides flowsheet technology and service solutions for the mining and cement industries in North America, South America, Europe, North and Sub-Saharan Africa, the Middle East, Central and South Asia, the Asia Pacific, and Australia. It operates in three segments: Mining, Cement, and Non-Core Activities. The company provides mining equipment, accessories, spare parts, and wear parts for use in centrifugation and classification; conveying; crushing and sizing; filtration; flotation and attrition; hydromet; material handling; milling and grinding; mine shaft systems; precious metals recovery; process control and optimisation; pyromet; sampling, preparation and analysis; screening; slurry pumping; thickening and clarifying; and wear solutions. It offers online mining equipment and process training courses; mining service centers; testing and research services; and operational services, including PerformanceIQ, online condition monitoring, precious metals, gravity concentrator, asset health, and mine planning services, as well as operating procedure audits, liner profiling and scanning, technical advisory, electrical and automation audits, and upgrades and rebuilds. The company sells its products under the ABON, AIRLOQ, AIRTECH, BUFFALO, Dorr-Oliver, EXCEL, Fuller, KREBS, MAAG GEAR, PFISTER, and VENTOMATIC brands. It serves the aggregates, cement, chemical, food and pharmaceuticals, mining, oil and gas refining, port and terminals, power utilities, pulp and paper, steel, waste to energy, and water treatment industries. The company was formerly known as FLS Industries and changed its name to FLSmidth & Co. A/S in January 2005. FLSmidth & Co. A/S was founded in 1882 and is headquartered in Valby, Denmark.
help-icon Live chat